{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:17:58Z","timestamp":1777648678810,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12094-017-1613-6","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T16:39:09Z","timestamp":1484584749000},"page":"785-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-4087","authenticated-orcid":false,"given":"M. A.","family":"Altinoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Guloksuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130.","family":"Elmaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"issue":"2","key":"1613_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1613_CR2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3892\/ol.2013.1126","volume":"5","author":"MB Cabanne","year":"2013","unstructured":"Cabanne MB, Ma QD, Mecum L, Jandial R, Siddiqi J, Chen MY. Prevalence of hepatitis B and C in patients with meningiomas and glioblastoma multiforme. Oncol Lett. 2013;5(3):783\u20136.","journal-title":"Oncol Lett"},{"issue":"4","key":"1613_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.semdp.2016.04.007","volume":"33","author":"MR Wick","year":"2016","unstructured":"Wick MR. Cutaneous melanoma: A current overview. Semin Diagn Pathol. 2016;33(4):225\u201341.","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"1613_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-016-0554-5","volume":"18","author":"K Wood","year":"2016","unstructured":"Wood K, Luke JJ. Optimal Use of BRAF Targeting Therapy in the Immunotherapy Era. Curr Oncol Rep. 2016;18(11):67. doi: 10.1007\/s11912-016-0554-5 .","journal-title":"Curr Oncol Rep"},{"issue":"16","key":"1613_CR5","doi-asserted-by":"publisher","first-page":"30866","DOI":"10.1016\/j.ejso.2016.07.145","volume":"S0748\u20137983","author":"C Franklin","year":"2016","unstructured":"Franklin C, Livingstone E, Roesch A, Schilling B, Schadendorf D. Immunotherapy in melanoma: Recent advances and future directions. Eur J Surg Oncol. 2016;S0748\u20137983(16):30866\u2013966. doi: 10.1016\/j.ejso.2016.07.145 .","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"1613_CR6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/scientificamerican1114-54","volume":"311","author":"DJ Mahoney","year":"2014","unstructured":"Mahoney DJ, Stojdl DF, Laird G. Virus therapy for cancer. Sci Am. 2014;311(5):54\u20139.","journal-title":"Sci Am"},{"key":"1613_CR7","first-page":"82","volume":"9","author":"N DePace","year":"1912","unstructured":"DePace N. Sulla Scomparsa di un enorme cancro begetante del callo dell\u2019utero senza cura chirurgica. Ginecoligia. 1912;9:82.","journal-title":"Ginecoligia"},{"issue":"5","key":"1613_CR8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archderm.1950.01530180083015","volume":"62","author":"GT Pack","year":"1950","unstructured":"Pack GT. Note on the experimental use of rabies vaccine for melanomatosis. AMA Arch Derm Syphilol. 1950;62(5):694\u20135.","journal-title":"AMA Arch Derm Syphilol"},{"issue":"4","key":"1613_CR9","first-page":"728","volume":"27","author":"GK Higgins","year":"1951","unstructured":"Higgins GK, Pack GT. The effects of virus therapy on the microscopic structure of human melanomas. Am J Pathol. 1951;27(4):728\u20139.","journal-title":"Am J Pathol"},{"key":"1613_CR10","first-page":"38","volume":"3","author":"FV Filipov","year":"1988","unstructured":"Filipov FV. A trial of rabies vaccine treatment of patients with glioblastoma multiforme. Zh Vopr Neirokhir Im NN Burdenko. 1988;3:38\u201340.","journal-title":"Zh Vopr Neirokhir Im NN Burdenko"},{"issue":"1","key":"1613_CR11","first-page":"49","volume":"2","author":"PV Philipov","year":"2009","unstructured":"Philipov PV. Adjuvant treatment of brain glioblastoma multiforme w\u0131th rabies vaccine, deferoxamine and d-penicillamine: a pilot study. J Biomed Clin Res. 2009;2(1):49\u201353.","journal-title":"J Biomed Clin Res"},{"issue":"1 Supplement","key":"1613_CR12","first-page":"126","volume":"190","author":"E Bongiorno","year":"2013","unstructured":"Bongiorno E, Morin-Brureau M, Barkhouse D, Faber M, Dietzschold B, Hooper D. A novel rabies virus-based glioma immunotherapeutic strategy targeting survivin (P4440). J Immunol. 2013;190(1 Supplement):126-5.","journal-title":"J Immunol."},{"issue":"3","key":"1613_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1099\/0022-1317-19-3-285","volume":"19","author":"SM Desai","year":"1973","unstructured":"Desai SM, Sehgal PB, Nanavati AN, Shirodkar MV. A rabies-induced serum factor inhibiting Rous sarcoma virus in chicks. J Gen Virol. 1973;19(3):285\u201393.","journal-title":"J Gen Virol"},{"issue":"20","key":"1613_CR14","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.1128\/JVI.00977-09","volume":"83","author":"G Castel","year":"2009","unstructured":"Castel G, Cht\u00e9oui M, Caignard G, Pr\u00e9haud C, M\u00e9houas S, R\u00e9al E, et al. Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity. J Virol. 2009;83(20):10808\u201320.","journal-title":"J Virol"},{"key":"1613_CR15","first-page":"175","volume-title":"Virology: principles and applications","author":"J Carter","year":"2007","unstructured":"Carter J, Saunders VA. Virology: principles and applications. Chichester: Wiley; 2007. p. 175."},{"issue":"22","key":"1613_CR16","doi-asserted-by":"crossref","first-page":"12327","DOI":"10.1128\/JVI.02132-13","volume":"87","author":"S Yamaoka","year":"2013","unstructured":"Yamaoka S, Ito N, Ohka S, Kaneda S, Nakamura H, Agari T, et al. Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness. J Virol. 2013;87(22):12327\u201338.","journal-title":"J Virol"},{"issue":"2","key":"1613_CR17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2005.04.004","volume":"111","author":"S Finke","year":"2005","unstructured":"Finke S, Conzelmann KK. Replication strategies of rabies virus. Virus Res. 2005;111(2):120\u201331.","journal-title":"Virus Res"},{"issue":"24","key":"1613_CR18","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","volume":"17","author":"C Tuffereau","year":"1998","unstructured":"Tuffereau C, B\u00e9n\u00e9jean J, Blondel D, Kieffer B, Flamand A. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 1998;17(24):7250\u20139.","journal-title":"EMBO J"},{"issue":"7316","key":"1613_CR19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(63)90004-7","volume":"2","author":"N Hashem","year":"1963","unstructured":"Hashem N, Barr ML. Mitogenic effect of rabies vaccine on cultures of lymphocytes in diseases of the nervous system. Lancet. 1963;2(7316):1029\u201330.","journal-title":"Lancet"},{"issue":"40","key":"1613_CR20","doi-asserted-by":"crossref","first-page":"37655","DOI":"10.1074\/jbc.M201374200","volume":"277","author":"C Langevin","year":"2002","unstructured":"Langevin C, Jaaro H, Bressanelli S, Fainzilber M, Tuffereau C. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J Biol Chem. 2002;277(40):37655\u201362.","journal-title":"J Biol Chem"},{"issue":"3","key":"1613_CR21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/bm401906p","volume":"15","author":"Y Gao","year":"2014","unstructured":"Gao Y, Wang ZY, Zhang J, Zhang Y, Huo H, Wang T, et al. RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain. Biomacromolecules. 2014;15(3):1010\u20138.","journal-title":"Biomacromolecules"},{"key":"1613_CR22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2015.02.007","volume":"71","author":"M Gooding","year":"2015","unstructured":"Gooding M, Malhotra M, McCarthy DJ, Godinho BM, Cryan JF, Darcy R, et al. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis. Eur J Pharm Sci. 2015;71:80\u201392.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"1613_CR23","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.4049\/jimmunol.1501274","volume":"195","author":"A Lebrun","year":"2015","unstructured":"Lebrun A, Portocarrero C, Kean RB, Barkhouse DA, Faber M, Hooper DC. T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue. J Immunol. 2015;195(9):4358\u201368.","journal-title":"J Immunol"},{"issue":"3","key":"1613_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/fvl.10.88","volume":"6","author":"DC Hooper","year":"2011","unstructured":"Hooper DC, Roy A, Kean RB, Phares TW, Barkhouse DA. Therapeutic immune clearance of rabies virus from the CNS. Future Virol. 2011;6(3):387\u201397.","journal-title":"Future Virol"},{"issue":"29","key":"1613_CR25","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1016\/j.vaccine.2010.04.090","volume":"28","author":"A Saraya","year":"2010","unstructured":"Saraya A, Wacharapluesadee S, Khawplod P, Tepsumethanon S, Briggs D, Asawavichienjinda T, et al. A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens. Vaccine. 2010;28(29):4553\u20137.","journal-title":"Vaccine"},{"issue":"2","key":"1613_CR26","first-page":"328","volume":"70","author":"K Korver","year":"1987","unstructured":"Korver K, Boeschoten EW, Krediet RT, van Steenis G, Schellekens PT. Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states. Clin Exp Immunol. 1987;70(2):328\u201335.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"1613_CR27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1809.111833","volume":"18","author":"E Kopel","year":"2012","unstructured":"Kopel E, Oren G, Sidi Y, David D. Inadequate antibody response to rabies vaccine in immunocompromised patient. Emerg Infect Dis. 2012;18(9):1493\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"1613_CR28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/14760584.2015.1011134","volume":"14","author":"A Giesen","year":"2015","unstructured":"Giesen A, Gniel D, Malerczyk C. 30 Years of rabies vaccination with Rabipur: a summary of clinical data and global experience. Expert Rev Vaccines. 2015;14(3):351\u201367.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"1613_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/MMBR.60.3.473-482.1996","volume":"60","author":"BT Huber","year":"1996","unstructured":"Huber BT, Hsu PN, Sutkowski N. Virus-encoded superantigens. Microbiol Rev. 1996;60(3):473\u201382.","journal-title":"Microbiol Rev"},{"issue":"23","key":"1613_CR30","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","volume":"28","author":"N Johnson","year":"2010","unstructured":"Johnson N, Cunningham AF, Fooks AR. The immune response to rabies virus infection and vaccination. Vaccine. 2010;28(23):3896\u2013901.","journal-title":"Vaccine"},{"issue":"1","key":"1613_CR31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsb.2011.07.003","volume":"176","author":"P Guichard","year":"2011","unstructured":"Guichard P, Krell T, Chevalier M, Vaysse C, Adam O, Ronzon F, Marco S. Three dimensional morphology of rabies virus studied by cryo-electron tomography. J Struct Biol. 2011;176(1):32\u201340.","journal-title":"J Struct Biol"},{"issue":"3","key":"1613_CR32","first-page":"49","volume":"310","author":"S Faiderbe","year":"1989","unstructured":"Faiderbe S, Chagnaud JL, Wafflart J, Geffard M. Autoantibodies directed against membrane phospholipid in serum in patients with malignant tumors. C R Acad Sci III. 1989;310(3):49\u201352.","journal-title":"C R Acad Sci III"},{"issue":"1","key":"1613_CR33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","volume":"11","author":"M Lafon","year":"2005","unstructured":"Lafon M. Rabies virus receptors. J Neurovirol. 2005;11(1):82\u20137.","journal-title":"J Neurovirol"},{"issue":"7","key":"1613_CR34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc1649","volume":"5","author":"MM Fuster","year":"2005","unstructured":"Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005;5(7):526\u201342.","journal-title":"Nat Rev Cancer"},{"issue":"34","key":"1613_CR35","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1016\/j.vaccine.2009.05.055","volume":"27","author":"M Houimel","year":"2009","unstructured":"Houimel M, Dellagi K. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Vaccine. 2009;27(34):4648\u201355.","journal-title":"Vaccine"},{"key":"1613_CR36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.virol.2016.08.034","volume":"498","author":"SG Buthelezi","year":"2016","unstructured":"Buthelezi SG, Dirr HW, Chakauya E, Chikwamba R, Martens L, Tsekoa TL, Stoychev SH, Vandermarliere E. The Lyssavirus glycoprotein: A key to cross-immunity. Virology. 2016;498:250\u20136.","journal-title":"Virology"},{"issue":"9","key":"1613_CR37","doi-asserted-by":"publisher","first-page":"e0137503","DOI":"10.1371\/journal.pone.0137503","volume":"10","author":"J Schwartzbaum","year":"2015","unstructured":"Schwartzbaum J, Seweryn M, Holloman C, Harris R, Handelman SK, Rempala GA, Huang RP, Burkholder B, Brandemihl A, Kallberg H, Johannesen TB, Ahlbom A, Feychting M, Grimsrud TK. Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma. PLoS One. 2015;10(9):e0137503. doi: 10.1371\/journal.pone.0137503 .","journal-title":"PLoS One"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-017-1613-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T02:06:09Z","timestamp":1601345169000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-017-1613-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1007\/s12094-017-1613-6","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}